Pregabalin for chemotherapy-induced neuropathy: background and rationale for further study.
Mellar P DavisCharles LoprinziPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)
Chemotherapy-induced neuropathy is difficult to manage, and the pain associated with neuropathy is poorly responsive to gabapentin in a randomized trial. Duloxetine is the only drug that has been found to be effective in reducing pain from chemotherapy neuropathy. In this qualitative review, the use of pregabalin for chemotherapy-induced neuropathy is discussed including the rationale and pharmacological reasons why pregabalin should be considered in a large, randomized placebo-controlled trial.